Amgen Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 95
  • Portfolio
  • 21
  • Exits
  • 48
Exits

Amgen Ventures General Information

Description

Founded in 2004, Amgen Ventures is the corporate venture capital arm of Amgen based in Thousand Oaks, California. The firm prefers to invest in seed-stage, early-stage. growth-stage, and later-stage companies. The firm seeks to invest in healthcare, life sciences, manufacturing, digital health, health technology, oncology sectors in Europe and North America.

Contact Information

Year Founded
2004
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • One Amgen Center Drive
  • Thousand Oaks, CA 91320
  • United States
+1 (805) 000-0000

Amgen Ventures Investments (95)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
CancerIQ 03-Mar-2022 Later Stage VC 0000 Decision/Risk Analysis Generating Revenue
00000000 000000000 31-Jan-2022 00000 00000 0000 Discovery Tools (Healthcare) Pre-Clinical Trials
00000 000 20-Dec-2021 0000 0000 Drug Discovery Generating Revenue
00000000 000000000 09-Sep-2021 00000 00000 00000 Drug Discovery Generating Revenue
000000 0000000 25-Aug-2021 00000 00000 0000 Clinics/Outpatient Services Generating Revenue
00000 00000000000 26-May-2021 00000 00000 00000 Other Healthcare Technology Systems Generating Revenue
00000000000 000000 18-May-2021 00000 00000 00000 Drug Discovery Clinical Trials - General
000000 00000000000 23-Apr-2021 00000 00000 0000 Biotechnology Product Development 00000 00000 00.0
Senti Bio 06-Jan-2021 Later Stage VC 00000 Drug Discovery Generating Revenue
DJS Antibodies 22-Dec-2020 Seed Round 00.000 Drug Discovery Startup
You’re viewing 10 of 95 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amgen Ventures Exits (48)

Company Name Exit Date Exit Type Exit Size
Science 37 07-Oct-2021 Reverse Merger 00000
0000000 0000000 16-Aug-2021 000000000000000000 00000
00000 00000000000 09-Jul-2021 000 00000
000000 00000000000 21-Aug-2020 000 00000
000000 00000000000 13-Jul-2020 000 00000
0000000 000 01-Jan-2020 0000000000: 000000
000000000 00000000 28-Mar-2019 000 00000
0000000 07-Feb-2019 000 00000
Opsona Therapeutics 13-Jan-2019 Bankruptcy: Liquidation
Sutro Biopharma 27-Sep-2018 IPO 0000
You’re viewing 10 of 48 exits. Get the full list »

Amgen Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Amgen Ventures Team (8)

Name Title Deals Funds Boards Office
Janis Naeve Ph.D Managing Director 00 0 0 South San Francisco, CA
Gladys Nunez Principal 0 0 0 Cambridge, MA
Rachna Khosla Senior Vice President, Business Development, Amgen Thousand Oaks, CA
You’re viewing 3 of 8 team members. Get the full list »

Amgen Ventures Co-Investors (209)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 7 0 0 Series chart Industry bar
Dementia Discovery Fund 0 0 Series chart Industry bar
GV 0 0 0 Series chart Industry bar
Polaris Partners 0 0 0 Series chart Industry bar
SV Health Investors 0 0 Series chart Industry bar
You’re viewing 5 of 209 co-investors. Get the full list »